Tandem Diabetes Care
TNDM
66 hedge funds and large institutions have $160M invested in Tandem Diabetes Care in 2014 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 21 reducing their positions, and 14 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 21
2% less call options, than puts
Call options by funds: $1.27M | Put options by funds: $1.29M
7% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 14
4% less funds holding
Funds holding: 69 → 66 (-3)
5% less capital invested
Capital invested by funds: $170M → $160M (-$9.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$5.74M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$5.05M |
| 3 |
ACM
Apex Capital Management
Dayton,
Ohio
|
+$4.42M |
| 4 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$2.48M |
| 5 |
Goldman Sachs
New York
|
+$1.43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$7.93M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$7.4M |
| 3 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$4.7M |
| 4 |
VAM
Visium Asset Management
New York
|
-$1.05M |
| 5 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$908K |
TNDM Hedge Fund Activity: Q4 2014 in Review
66 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q4 2014, worth a combined $160M — down 5.4% from $170M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of TNDM and 13 opened new positions — a net loss of 1 holder — while 21 trimmed existing stakes and 21 added.
The largest buyer was BlackRock Advisors, adding an estimated $5.74M. The largest seller was Jennison Associates, cutting an estimated $7.93M.
- 66 institutional investors held Tandem Diabetes Care (TNDM) as of Q4 2014, down from 69 in Q3 2014.
- Funds reported $160M of Tandem Diabetes Care stock for Q4 2014, down 5.4% quarter-over-quarter.
- 13 funds opened new Tandem Diabetes Care positions in Q4 2014 and 14 closed out, a net change of -1 holder.
- The largest Tandem Diabetes Care buyer in Q4 2014 was BlackRock Advisors, an estimated $5.74M added.
- The largest Tandem Diabetes Care seller in Q4 2014 was Jennison Associates, an estimated $7.93M sold.
Based on aggregated 13F filings for Q4 2014.